Business Context and Reporting Period
Company: Pacific Biosciences of California, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: November 2, 2016
Reporting Period: Third fiscal quarter ended September 30, 2016
This filing serves as a notification that the company announced its financial results for the third quarter of 2016. The detailed results are contained in a press release (Exhibit 99.1) incorporated by reference.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical data. The filing explicitly states that the financial results are furnished in the attached press release (Exhibit 99.1) and are not included in the body of this document.
- Revenue: Not provided in this text.
- Profit/Loss: Not provided in this text.
- Cash Flow: Not provided in this text.
- Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
Material Changes
The filing text does not provide specific data to compare against the prior comparable period. It only confirms the announcement of the Q3 2016 results.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. These items are expected to be found in the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 2, 2016) for actual revenue, net loss, and cash position figures.
- Verify the specific year-over-year and quarter-over-quarter changes in operating metrics.
- Check the press release for any updated full-year 2016 guidance or strategic shifts.
- Confirm the status of the company's cash runway and burn rate as detailed in the full financial statement.